Exelixis Inc. Common Stock vs SpaceX — how do they compare? Exelixis Inc. Common Stock trades at $59.11 (market cap $14.62B), while SpaceX trades at $166.89 (market cap $2.18T). The key difference: SpaceX is far larger — about 149.1× Exelixis Inc. Common Stock's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and SpaceX for 41 Days on average.
| EXEL | SPCX | |
|---|---|---|
Market Cap | $14.62B | $2.18T |
Volume | 2,684,957 | 68,508,567 |
Sector | Health | Industrials |
52-Week High | $59.13 | $202.09 |
52-Week Low | $34.54 | $108.27 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $13.95B | $2.12T |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →